Preliminary Program subject to change
Bioinformatics
Presentation Type	Oral
Summary Statement
Presider:	Nichols Murgolo, Schering-Plough Research Institute, Kenilworth, NJ
Welcoming Remarks Ezetimibe mechanism of action: what did we learn from gene chips? Jeffrey Yuan1, Diane Shevell1, Peter S. Linsley2, Patricia A. Detmers1 and John R. Thompson1, (1)Merck and Co., Inc., Rahway, NJ, (2)Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co., Inc, Seattle, WA Phylogenetic Analysis and Classification of Human Protein Kinases Targeting the ATP Binding Site Philip W. Mui, Glaxo SmithKline, King of Prussia, PA Break Phenotype Mapping of Genes Qing Zhang, Schering Plough Research Institute, Kenilworth, NJ Identification of tumor associated SNPs based on EST analysis Wei Ding1, Mitch Kostich2, Luquan Wang3, Ping Qiu1, Jonathan Greene1 and Marco Hernandez1, (1)Schering-Plough Research Institute, Kenilworth, NJ, (2)Environmental Protection Agency, Cincinnati, OH, (3)GenScript Corporate, Piscataway, NJ

General Submissions